GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses
Sean D. Donevan, Michael A. Rogawski(National Institutes of Health)
Cited by 359
Abstract
Related Papers
No related papers found
Powered by citation graph analysis